(Q51734153)

11 April 2018

title

Effective impairment of myeloma cells and their progenitors by hyperthermia. (English)

1 reference

11 April 2018

author name string

Hirokazu Miki

1

1 reference

11 April 2018

Shingen Nakamura

2

1 reference

11 April 2018

Asuka Oda

3

1 reference

11 April 2018

Hirofumi Tenshin

4

1 reference

11 April 2018

Jumpei Teramachi

5

1 reference

11 April 2018

Masahiro Hiasa

6

1 reference

11 April 2018

Ariunzaya Bat-Erdene

7

1 reference

11 April 2018

Yusaku Maeda

8

1 reference

11 April 2018

Masahiro Oura

9

1 reference

11 April 2018

Mamiko Takahashi

10

1 reference

11 April 2018

Masami Iwasa

11

1 reference

11 April 2018

Takeshi Harada

12

1 reference

11 April 2018

Shiro Fujii

13

1 reference

11 April 2018

Kiyoe Kurahashi

14

1 reference

11 April 2018

Sumiko Yoshida

15

1 reference

11 April 2018

Kumiko Kagawa

16

1 reference

11 April 2018

Itsuro Endo

17

1 reference

11 April 2018

Kenichi Aihara

18

1 reference

11 April 2018

Mariko Ikuo

19

1 reference

11 April 2018

Kohji Itoh

20

1 reference

11 April 2018

Koichiro Hayashi

21

1 reference

11 April 2018

Michihiro Nakamura

22

1 reference

11 April 2018

Masahiro Abe

23

1 reference

11 April 2018

language of work or name

English

0 references

publication date

7 December 2017

1 reference

11 April 2018

published in

Oncotarget

1 reference

11 April 2018

volume

9

1 reference

11 April 2018

issue

12

1 reference

11 April 2018

page(s)

10307-10316

1 reference

11 April 2018

Control of Pim2 kinase stability and expression in transformed human haematopoietic cells

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5828190

Effective impairment of myeloma cells and their progenitors by blockade of monocarboxylate transportation

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5828190

Magnetic Nanoparticles in Cancer Theranostics

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5828190

Magnetically responsive smart nanoparticles for cancer treatment with a combination of magnetic hyperthermia and remote-control drug release

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5828190

Concise review: Defining and targeting myeloma stem cell-like cells

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5828190

Combination with a defucosylated anti-HM1.24 monoclonal antibody plus lenalidomide induces marked ADCC against myeloma cells and their progenitors

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5828190

Superparamagnetic nanoparticle clusters for cancer theranostics combining magnetic resonance imaging and hyperthermia treatment

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5828190

BCL6 breaks occur at different AID sequence motifs in Ig-BCL6 and non-Ig-BCL6 rearrangements

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5828190

Small molecule antibody targeting HLA class I inhibits myeloma cancer stem cells by repressing pluripotency-associated transcription factors

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5828190

The serine/threonine kinase Pim-2 is a novel anti-apoptotic mediator in myeloma cells

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5828190

The cancer stem cell: premises, promises and challenges

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5828190

Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5828190

22 May 2018

Pathogenesis of myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5828190

Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5828190

A side order of stem cells: the SP phenotype

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5828190

A role for Wnt signalling in self-renewal of haematopoietic stem cells

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5828190

Clinical drug resistance linked to interconvertible phenotypic and functional states of tumor-propagating cells in multiple myeloma.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5828190

SUnSET, a nonradioactive method to monitor protein synthesis.

14 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5828190

Role for macrophage inflammatory protein (MIP)-1alpha and MIP-1beta in the development of osteolytic lesions in multiple myeloma

14 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/29535808

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.18632/ONCOTARGET.23121

1 reference

11 April 2018

PMCID

5828190

1 reference

11 April 2018

PubMed ID

29535808

1 reference

11 April 2018